<DOC>
	<DOCNO>NCT02030574</DOCNO>
	<brief_summary>The standard treatment muscle invasive bladder cancer administer chemotherapy approximately 3 month surgery remove bladder . Chemotherapy may reduce size cancer bladder surgery also help reduce chance bladder cancer come back ( metastasize ) part body bladder surgery . This study involve test cisplatin low weekly dos gemcitabine.The purpose study test effect , good bad , low dose weekly cisplatin gemcitabine .</brief_summary>
	<brief_title>Neoadjuvant Gemcitabine Fractionated , Weekly Cisplatin For Muscle Invasive Bladder Cancer Patients Not Candidates For High Dose Cisplatin</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>1 . Pathologically confirm muscleinvasive urothelial ( transitional cell ) carcinoma bladder upper genitourinary tract . 2 . Stage T2T4a . Patients may nodal disease must evidence distant metastasis patient must candidate radical cystectomy determine urologic surgeon ( note from/confirmation surgeon require ) . 3 . No prior systemic therapy urothelial carcinoma . Prior intravesical therapy allow . 4 . Patients determine treat oncologist candidate high dose cisplatin ( &gt; 70mg/m2 ) due medical comorbidities . 5 . Creatinine Clearance ( CrCL eCCr ) ) &gt; 25 mL/min calculate use CockcroftGault formula 6 . Patients without serious medical risk factor involve major organ system investigator considers unsafe patient receive protocol treatment study gemcitabine weekly fractionate cisplatin . 7 . Preexisting neuropathy &lt; grade 2 . 8 . No prior invasive malignancy within prior two year . However , prior history nonmuscle invasive bladder cancer patient early stage malignancy expect require treatment next 2 year ( early stage , resect breast cancer , asymptomatic prostate cancer ) eligible . 9 . ECOG performance status 0 1 . 10 . Age ≥ 18 year age . 11 . Not pregnant nursing . Women child bear potential must negative serum urine pregnancy test ( minimum sensitivity 25 IU/L equivalent unit HCG ) within 7 day prior begin treatment . Postmenopausal woman ( surgical menopause lack menses &gt; 12 month ) need pregnancy test , please document status . 12 . Required Initial Laboratory Values : Neutrophils ≥ 1,000/μl Platelet count ≥ 100,000/μl Total bilirubin ≤ 1.5 x ULN . AST ( SGOT ) &amp; ALT ( SGPT ) ≤ 3.0 x ULN 1 . Metastatic disease . 2 . Prior hypersensitivity platinum investigator opinion would put patient risk reexposed 3 . Small cell cancer bladder pure adenocarcinoma . Patients mixed histology urothelial carcinoma sarcomatoid feature , squamous differentiation adenocarcinoma allow long transitional cell cancer predominant pathologic subtype .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>